Long-term medical treatment for Parkinson’s disease
- Cite this article as:
- Bertoni, J.M., Prendes, JL. & Sprenkle, P. Curr Treat Options Neurol (2001) 3: 495. doi:10.1007/s11940-001-0012-y
- 50 Downloads
The authors of this paper view Parkinson’s disease (PD) as a clinically defined progressive syndrome of resting limb tremor, bradykinesia, muscle rigidity, and a shuffling unsteady gait that responds well to dopaminergic medications. Parkinson’s disease is a not a single entity, but rather a syndrome with diverse causes, with both genetic and environmental risk factors [1••]. The clinician’s concern is to rule out other entities, especially those having another specific treatment, and to give PD patients the best short- and long-term benefit, with the least possible unwanted side effects.